PLATFORM

Microbiome Platform

From Healbiome, our microbiome bank, and PRIME FMT to obligate-anaerobe multi-strain drug development and NGS-based personalized microbiome analysis — explore BioBankHealing's core platform in one place.

FMT Treatment

Korea's No.1 FMT (Fecal Microbiota Transplantation) — BioBankHealing operates Korea's largest stool bank (Healbiome). With a systematic process spanning healthy-donor recruitment, screening, and management, we deliver safe, standardized microbiome-based treatment solutions.

What is FMT?
Fecal microbiota transplantation (FMT) is a treatment in which microbes from a healthy donor are specially processed into a microbial solution and transplanted into the patient — typically via endoscopy — restoring a disrupted gut bacterial composition to normal.
Who is it for?
FMT is indicated for patients whose gut bacterial composition has been disrupted by antibiotic after-effects or side effects, or in whom overgrowth of Clostridioides difficile in the colon has caused colitis or severe diarrhea that is refractory to, or recurs after, conventional treatment.
PRIME FMT six-step process — donor screening, precision analysis, FMT manufacturing, AI-based matching, personalized treatment, data tracking and research
Personalized FMT platform

PRIME FMT

Precision Reconstruction of Individual Microbiome Ecosystems

PRIME is BioBankHealing's proprietary personalized FMT platform. Built on a rigorous donor-screening system and accumulated clinical data, it analyzes each patient's gut microbial imbalance and precisely reconstructs an optimal microbial ecosystem.

Drawing on the expertise accumulated through operating Healbiome and on next-generation sequencing (NGS) technology, we deliver personalized FMT therapy optimized to each patient's characteristics and continue to develop safer, more standardized treatment solutions.

Rigorous donor screening · NGS · Personalized FMT

Healbiome products

BioBankHealing's FMT products, developed with proven transplantation technology and a standardized manufacturing process.

BioBankHealing FMT solution — fecal microbiota transplant solution, 250 ml
FMT solution

BioBankHealing's FMT solution and transplantation
technology are already proven effective.

Our FMT solution achieves a treatment efficacy of over 90%. Made from high-quality Super Donor material, its safety has been demonstrated across ten years of clinical use. A systematic FMT donor selection process, together with examination and screening at SNU Bundang Hospital, keeps quality consistently high.

BioBankHealing FMT solution

Fecal microbiota transplant solution (250 ml)

  • Over 90% treatment efficacy
  • High-quality solution from healthy donors
  • Safety demonstrated over ten years of clinical use

What sets the BBH solution apart

Systematic FMT donor screening
  • Examination and screening at SNU Bundang Hospital
  • Donors selected after specialist consultation
  • Stool condition checked at every donation
5+ year supply agreements with Korea's largest university hospitals
  • Solution delivered precisely on the scheduled procedure date
  • Over 90% treatment efficacy
  • Safety verified through 5+ years of clinical use
Know-how from being Asia's first microbiome bank
  • Korea's largest supplier of FMT solution
  • Manufacturing patent held (Reg. No. 10-2479275)
Quick, responsive support
  • Dedicated FMT staff
  • Dedicated FMT KakaoTalk channel
SUPER GUT — an oral fecal microbiota transplant capsule with enteric coating
A next-generation FMT capsule platform for restoring gut microbial balance

SUPER GUT

SUPER GUT is an oral fecal microbiota transplant capsule developed with rigorous donor screening, a standardized manufacturing process, and enteric-coating technology. Its non-invasive oral format improves patient convenience, while frozen-encapsulation technology and a quality-management system are designed to preserve microbial viability and product quality.

Formulation and dosage

8 × size-0 capsules or 20 × size-4 capsules

Key features

Super Donor Screening

Standardized manufacturing and quality control

Enteric-coated capsule

Microbial viability preserved by an anaerobic manufacturing process

Non-invasive oral administration

Patient convenience and safety

Supply process for medical institutions

Consultation & Request 상담 및 의뢰 Receive the clinician's indication and supply request; confirm patient status and schedule
Case Review 공급 적합성 검토 Review the indication and supply schedule; confirm the product and administration plan
Product Release 제품 출고 준비 Select the verified FMT product and release it after quality control (QC)
Cold Chain Delivery 콜드체인 배송 Maintained at ultra-low freezing temperatures and delivered rapidly to medical institutions nationwide
Clinical Support 치료 후 협력 지원 Clinician support and product inquiries, with ongoing clinical collaboration and feedback
CLINICAL CASE

Recurrent Clostridioides difficile infection

재발성 클로스트리디오이데스 디피실 감염증 · A case from SNU Bundang Hospital

In a patient with repeated recurrence and refractoriness to conventional antibiotic therapy, the gut microbial ecosystem recovered after FMT, with significant improvement confirmed in both clinical symptoms and endoscopic findings.

Colonoscopy before FMT — severe inflammation and pseudomembranous lesions
Before FMTSevere inflammation and pseudomembranous lesions observed
Colonoscopy during FMT — transplantation of the standardized FMT solution
During FMTStandardized FMT performed
Colonoscopy after FMT — resolution of inflammation and recovery of normal mucosa
After FMTInflammation resolved and normal mucosa restored

Supplying hospitals

We supply FMT solution and capsules to more than 60 hospitals and clinics nationwide, driving the adoption of microbiome-based therapy across Korea.